<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="jpd-5-4-jpd150685-t001" orientation="portrait" position="float">
 <label>Table 1</label>
 <caption>
  <p>Conceptual stages of Parkinson’s disease</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col align="justify" span="1"/>
  </colgroup>
  <thead valign="top">
   <tr>
    <td rowspan="1" colspan="1">Phases of PD</td>
    <td rowspan="1" colspan="1">Clinical status</td>
    <td rowspan="1" colspan="1">Pathology</td>
    <td rowspan="1" colspan="1">Comments</td>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="1" colspan="1">Phase 1 - preclinical</td>
    <td rowspan="1" colspan="1">No clinical signs or symptoms</td>
    <td rowspan="1" colspan="1">PD-specific pathology assumed to be present</td>
    <td rowspan="1" colspan="1">Supported by biomarkers (genetic, molecular, and/or imaging)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Phase 2 - prodromal</td>
    <td rowspan="1" colspan="1">Early nonmotor symptoms±early subtle motor symptoms</td>
    <td rowspan="1" colspan="1">Extranigral PD pathology (Braak stages 1 and 2)±nigral PD pathology (&lt;40–60% cell loss; Braak Stage 3)</td>
    <td rowspan="1" colspan="1">Criteria yet to be defined based on clinical motor and nonmotor markers and nonclinical biomarkers. Two levels of certainty have been proposed [
     <xref rid="r19" ref-type="bibr">19</xref>]: Probable prodromal PD (high likelihood, e.g., &gt;80% ; sufficiently certain for neuroprotective trials) and possible prodromal PD (lower, but still substantial likelihood, e.g., 30% –80%)
    </td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Phase 3 - motor</td>
    <td rowspan="1" colspan="1">Classical motor manifestations are present</td>
    <td rowspan="1" colspan="1">Nigral PD pathology (&gt;40–60% cell loss; Braak stages 3 to 6)</td>
    <td rowspan="1" colspan="1">Current clinical diagnostic criteria based on motor syndrome are met;±a variety on nonmotor symptoms may be present due to the extension of PD pathology</td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>Modified from Stern et al. 2012 [
   <xref rid="r18" ref-type="bibr">18</xref>].
  </p>
 </table-wrap-foot>
</table-wrap>
